C-Path Appoints Clinical Outcome Assessment Expert as New Executive Director Sonya Eremenco will lead C-Path’s PRO Consortium TUCSON, Ariz., August 5, 2021— Critical Path Institute (C-Path) announced it
Digital Health Technologies Hold Key to New Parkinson’s Treatments Global stakeholders come together to collaborate with urgency to address unmet needs for Parkinson’s therapies. TUCSON, Ariz., J
Launch of UNITE4TB Partnership Marks a New Era in Tuberculosis Treatment Development The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiat
C-Path Announces Health Care Leader Appointment to Board of Directors TUCSON, Ariz., July 8, 2021 — Critical Path Institute (C-Path) today announced the appointment of health care industry leader
Clinical Technology Expert and Experienced Neuroscientist Join C-Path in Executive Director Roles Scottie Kern and Dr. Terina N. Martínez Will Both Serve in Dual Positions TUCSON, Ariz., June 24, 2021 — Critical Path Instit
C-Path Virtual Workshop to Feature Latest Advances in Clinical Trials for T1D More than 300 Attendees and 20 Speakers Are Expected to Participate in the International Workshop, June 15-16 TUCSON, Ariz., May 2
C-Path Announces Accelerated Data Sharing Collaboration with Tufts Medical Center FDA Grant Supports Use of Real-World Data to Generate Real-World Evidence in Neonates TUCSON, Ariz., May 12, 2021 — Criti
C-Path Appoints Quantitative Sciences Expert as New Sr. Vice President Dr. Jeff Barrett will lead C-Path’s RDCA-DAP initiative focusing on rare disease data sharing and accelerating therapy devel
C-Path Selects New Leaders of Data Science and Quantitative Medicine TUCSON, Ariz., April 26, 2021 — Critical Path Institute (C-Path) has named Amanda J. Borens, M.S., as Executive Director of Data
C-Path Opens Access to Duchenne Regulatory Science Consortium Database Database will allow sharing of individual-level data with the goal of accelerating therapy development for Duchenne muscular dystr